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Embolotherapy for Pulmonary
Arteriovenous Malformations in Patients
without Hereditary Hemorrhagic
Telangiectasia
Objective: To evaluate the clinical and radiological outcomes of transcatheter
embolotherapy for treating sporadic pulmonary arteriovenous malformations
(PAVMs) that were not associated with hereditary hemorrhagic telangiectasia. 
Materials and Methods: Between January 2001 and June 2008, thirty-five
sporadic PAVMs were detected in 23 patients. The clinical follow up consisted of
assessing the changes of the signs and symptoms of the PAVMs, and radiologi-
cal evaluation with chest radiographs or chest CT scans.
Results: The lower lung regions (63%) and peripheral locations (86%) were
the common locations of the PAVMs. Thirty-four PAVMs (97%) had simple archi-
tecture (one arterial feeder within a single pulmonary segment). Technical suc-
cess was achieved in 33 PAVMs (94%); two cases of technical failure were due
to catheterization failure (n = 1) and too large a feeding artery (17 mm) that dis-
abled embolotherapy (n = 1). Coils and Amplatz vascular plugs were used in 30
and three PAVMs, respectively. Inadvertent placement of one coil (n = 1) and pul-
monary infarction (n = 1) occurred, but no relevant symptoms developed. For the
13 patients with available data, the mean arterial O2 saturation changed signifi-
cantly from 92% to 98%. Complete or near-complete involution of the sac was
observed in 30 of the 33 embolized PAVMs (91%). In these 33 embolized
PAVMs, the mean sac diameter significantly decreased from 17.83 mm to 0.68
mm.
Conclusion: Sporadic PAVMs are mostly the simple type with predominance
in the lower lobe and peripheral locations. Transcatheter embolotherapy with
coils or Amplatz vascular plugs is a safe and effective treatment for sporadic
PAVMs and this provides excellent functional and radiological improvement. 
ulmonary arteriovenous malformations (PAVMs) are abnormal
communications between the pulmonary arteries and veins without any
intervening capillary beds. Severe complications from PAVMs may
occur, including massive hemoptysis and hemothorax, as well as neurologic complica-
tions, including transient ischemic attack, cerebral stroke and cerebral abscess due to
the right-to-left shunting that facilitates the passage of septic emboli into the cerebral
circulation (1). Thus treating PAVMs is justified when this is technically feasible, and
even for PAVMs that are asymptomatic. About 70-95% of all PAVMs are associated
with hereditary hemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome)
(2-7), which is an autosomal dominant genetic disorder that is characterized by
recurrent epistaxis, mucocutaneous telangiectasia and visceral vascular involvement,
including arteriovenous communications that may develop in virtually any organ and
especially in the lungs (2, 3).
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PThe incidence of HHT is particularly high in the
American, European and Afro-Caribbean populations (1)
and there have been many reports on PAVMs associated
with HHT (1, 4-7). The sporadic types of PAVMs, which
are not associated with HHT, are rare, and there are only
limited reports on their clinical features, radiological
characteristics and treatment outcomes. The purpose of
this study was to evaluate the clinical and radiological
outcomes of performing transcatheter embolotherapy for
sporadic PAVMs. 
MATERIALS AND METHODS
The charts of the subjects of this study were reviewed
with the approval of our Institutional Review Board.
Informed consent for the chart review was waived.
Informed consent was obtained from all the patients at the
time of the procedures. 
Patients
Of a cohort of 25 consecutive patients with PAVMs and
who were referred for transcatheter embolotherapy
between January 2001 and June 2008, 23 (92%) had
sporadic PAVMs and these patients were included in this
report; the two excluded patients had PAVMs associated
with HHTs. HHT was diagnosed when at least two criteria
were met: 1) the patients had cutaneous telangiectasia,
epistaxis and/or visceral involvement such as pulmonary,
hepatic or central nervous system AVMs, and 2) there was
a first degree family history of HHT (8). The 23 included
patients consisted of 21 females and two males, and their
average age was 48.1 years (range: 12-75 years). 
Embolization Procedure
All the patients underwent complete diagnostic
pulmonary angiography before their embolotherapy. A 5-
Fr Cobra or Headhunter catheter (Cook, Bloomington, IN)
was used to access the pulmonary arteries in both lungs.
After selective catheterization, the feeding arteries of the
PAVMs were embolized, as close to the sac as possible,
with using coils or Amplatz vascular plugs (since 2007) of
an appropriate size. The embolic coils we used were
platinum coils with synthetic fibers (Tornado coils or
Nester coils, Cook). The coils were deployed until repeated
injections of contrast medium demonstrated the cessation
of flow through the PAVMs.
The choice of whether to use coils or Amplatz vascular
plugs was made at the discretion of the operator. The
diameter of the feeding artery was measured on the
diagnostic angiograms to select a coil of suitable size. The
coil diameter was overestimated to avoid accidental coil
migration. The true diameter of the artery at the site of coil
placement was determined from the diameter of the
selected catheter as a reference for magnification correc-
tions. After positioning the first coil, the second coil of the
same diameter or a smaller diameter was then positioned.
The patients with multiple PAVMs in both lungs were
sometimes treated in two sessions, depending on the
patient’s tolerance and the total amount of contrast
medium used.
Follow Up and Data Analysis
The clinical follow up consisted of assessing the changes
of the signs and symptoms of the PAVMs, and radiological
evaluation with chest radiographs and/or chest CT scans. 
The characteristics of the assessed PAVMs included their
number, a lobar location, a central or peripheral location,
the angioarchitecture, the diameters of the feeding artery
and the aneurysmal sac, the technical success, the compli-
cations during embolotherapy or follow up, the change of
the arterial oxygen saturation level and the clinical
outcome. 
Pulmonary arteriovenous malformations that were
located in the right upper, right middle and left upper lung
lobes were considered to be located in the upper lung
zones, and the PAVMs that were located in the right and
left lower lobes were considered to be located in the lower
lung zones. A peripheral location was defined as the lung
parenchyma within 4 cm of the pleural surface and a
central location was defined as the more centrally located
portion of the lung parenchyma (9). The simple type
angioarchitecture consisted of one or more arterial feeders
within a single pulmonary segment, whereas the complex
type had two or more arterial feeders from more than one
pulmonary segment (2, 6). The diffuse type was defined as
diffuse involvement of multiple segments or lobes with
numerous, variably sized lesions (10). The technical
success was defined as the successful embolization for all
visible PAVMs with observing no residual PAVM filling on
the final angiogram. The arterial oxygen saturation level
(SaO2), which is a parameter of the right-to-left shunt
fraction, was calculated by conducting arterial blood gas
analysis before and after embolization. 
The patient outcome was tracked to the most recent
radiological follow up. A PAVM was considered to have
been successfully treated if complete or near complete
involution (i.e., linear scar only) of the aneurismal sac was
noted on the follow-up chest CT scans (6). Disappearance
of a sac on the chest radiograph was considered acceptable
in those patients who had no follow-up CT scan if the sac
had been seen on the chest radiograph taken before
embolization (6). 
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cal significance of the changes of the SaO2 and the aneuris-
mal sac diameter. The SPSS version 14.0 statistical
package (SPSS, Chicago, IL) was used for all the statistical
analyses, with p values 0.05 indicating statistical signifi-
cance.
RESULTS
The PAVMs in all 23 patients were diagnosed as a result
of incidental imaging findings (n = 6, 26%), respiratory
symptoms (n = 15, 65%) or neurologic events (n = 2, 9%)
(Table 1). Embolotherapy improved the respiratory
symptoms in all 15 patients who had respiratory
symptoms. The neurologic manifestations such as brain
abscess and thalamic infarction with associated symptoms
were improved by surgical drainage and conservative
management, respectively, before embolotherapy.
A total of 35 PAVMs were detected on CT scans in 23
patients, with five patients (22%) having two or more
PAVMs each. Twenty-two (63%) PAVMs were located in
the lower lung zones (11 each in the right and left lower
lobes), and 13 (37%) in the upper lung zones (2 each in the
right and left upper lobes, respectively, and 9 in the right
middle lobe). Thirty (86%) PAVMs had a peripheral
location, and five (14%) had a central location. Thirty-four
(97%) PAVMs had simple angioarchitecture, and one (3%)
had diffuse angioarchitecture.
The mean diameter of the feeding arteries in the 34
simple PAVMs was 5.15 (median, 2.89 mm; range, 1.5-17
mm), with two arteries having of a diameter < 3 mm, 18
arteries had  a diameter in the range 3-5 mm, and 14
arteries had a diameter > 5 mm. In these 34 simple
PAVMs, the mean diameter of the aneurismal sac was
Shin et al.
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Table 1. Characteristics and Outcomes of Pulmonary Arteriovenous Malformations
Age/
Circumstances  No. 
Lobar  Embolic  Technical  Sac 
SaO2 F.U. 
No.
Gender
of  of
Location Materials Success Involution*
Change 
Months
Remarks
Diagnosis PAVMs (pre → post)
01 54 / F Chest discomfort 1 RLL Coil Yes Yes 97.8 → 99.8 17
02 71 / F Dyspnea 1 RML Coil Yes No 74 → 100 30
03 42 / F Asymptomatic 1 LLL Coil Yes Yes 98.3 → 98.1 07
04 31 / F Hemoptysis 1 RLL Coil Yes Yes NA 44
05 41 / F Dyspnea 9 RML, RLL,  Coil No in one PAVM  **Yes** 90.5 → 97.2 27 Inadvertent 
LLL (cath. failure) coil placement
06 40 / F Dyspnea 2 LLL,RLL Coil No in RLL  **Yes** 83.1 → 91.7 19 Right lower 
PAVM  lobectomy for 
(too large feeder) RLL PAVM
07 61 / F Dyspnea 2 LLL, LLL Coil Yes Yes 77.6 → 97 07
08 37 / F Hemoptysis 1 RML Coil Yes Yes 98.3 → 98.2 16
09 43 / F Hemoptysis 1 LUL Coil Yes Yes NA 07
10 52 / F Hemoptysis 1 RML Coil Yes No NA 30
11 28 / M Hemoptysis 2 RLL, LLL Coil Yes No in one  NA 01 Pulmonary 
PVAM infarction
12 65 / F Dyspnea 1 RUL Coil Yes Yes 96.6 → 97.4 25
13 66 / F Asymptomatic 1 LLL AVP Yes Yes NA 03
14 75 / F Chest discomfort 1 RUL Coil Yes Yes NA 06
15 38 / F Asymptomatic 1 RML Coil Yes Yes NA 13
16 22 / F Thalamic infarction 1 RLL Coil Yes Yes NA 13
17 82 / F Dyspnea 1 RLL Coil Yes Yes 95.7 → 96.8 12
18 52 / F Hemoptysis 1 RLL Coil Yes Yes 97 → 96.5 16
19 48 / F Hemoptysis 1 LLL AVP Yes Yes NA 01
20 35 / F Asymptomatic 1 LUL Coil Yes Yes 99.8 → 99.8 62
21 69 / F Asymptomatic 2 RML, RLL Coil Yes Yes NA 75 Diffuse type for 
RLL PAVM
22 12 / M Brain abscess 1 LLL Coil Yes Yes 92.4 → 97.6 01
23 43 / F Asymptomatic 1 RML AVP Yes Yes 95 → 99 03
Note.─ PAVMs = pulmonary arteriovenous malformations, RUL = right upper lobe, RML = right middle lobe, RLL = right lower lobe, LUL = left upper lobe, 
LLL = left lower lobe, AVP = Amplatz vascular plug, cath. failure = catheterization failure, Sac involution* means complete or near complete involution (i.e.
linear scar only) of aneurismal sac, Yes** for treated PAVM(s), NA = not applicable18.07 (median, 10.98 mm; range, 4-54 mm). The one
diffuse PAVM had an aneurismal sac diameter of 40 mm.
Of the 35 PAVMs, 33 (32 simple and one diffuse) were
successfully embolized with no residual filling, making the
technical success rate 94% (Figs. 1, 2). Twenty-two
patients had one session of embolotherapy, while one
patient received two sessions of embolotherapy because
there were nine PAVMs in both lungs. One to twenty three
coils were used for 29 simple PAVMs (average, 5.4 per
PAVM), whereas 54 coils were used for the one diffuse
type PAVM. Amplatz vascular plugs (6 or 12 mm in
diameter) were used for three simple PAVMs, which had
feeding artery diameters of 3, 8 and 10 mm (Fig. 2). Each
PAVM required only one vascular plug, with complete or
near-complete obliteration of the sac observed during
follow up. The vascular plug was oversized 30-50%
greater than the feeding artery diameter. 
The cases of technical failure were caused by failure of
catheterization (n = 1) or too large a feeding artery 
(17 mm) that disabled the embolotherapy (n = 1). The
former case showed no change in the sac size on the
follow-up CT scans; this patient did not undergo further
treatment. The latter case was not embolized due to the
high risk of coil migration into the right atrium; this patient
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ABC
Fig. 1. 40-year-old female with large
pulmonary arteriovenous malformation in
left lower lobe (Patient No. 6). Simple
radiograph (A), left selective pulmonary
arteriogram (B), and CT angiogram (C)
show large 32-mm-diameter pulmonary
arteriovenous malformation (arrows) with
single arterial feeder (arrowheads in C) and
single draining vein. Left pulmonary arteri-
ogram (D) after embolotherapy with placing
four Nester coils shows no evidence of
pulmonary arteriovenous malformation.
Simple radiograph (E) 19 months after
embolotherapy shows complete disappear-
ance of pulmonary arteriovenous malforma-
tion shadow. 
DEunderwent right lower lobectomy to remove the PAVM
five days later.
During embolotherapy, one coil was inadvertently
placed into the right upper pulmonary artery without any
symptomatic change in one patient (No. 5 in Table 1). In
another patient (No. 11 in Table 1), a follow-up CT scan
three weeks after embolotherapy showed a pulmonary
infarction distal to the embolized pulmonary artery 
(Fig. 3). His vague right chest pain subsided within several
days, and pleurisy did not develop.
The SaO2 follow-up data recorded 2-24 months after
embolotherapy was available for 13 patients. Their mean
arterial oxygen saturation changed significantly, from 92%
(range: 74.0 to 99.8%) before embolization to 98%
(range: 91.7 to 100%) after embolization (p = 0.027).
Radiological examinations, which consisted of chest CT
scans and radiography in 11 patients and chest radiography
only in 12 patients, during an average follow-up period of
18.88 months (range: 1-75 months) showed complete or
near-complete involution in 30 of 33 embolized PAVMs
(91%). In these 33 embolized PAVMs, the mean diameter
of the sac significantly decreased, from 17.83  9.89 mm
Shin et al.
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Fig. 2. 66-year-old female with inciden-
tally found pulmonary arteriovenous
malformation in left lower lobe (Patient
No. 13). Left selective pulmonary arteri-
ogram (A) shows 25-mm-diameter
pulmonary arteriovenous malformation
(arrows) with single arterial feeder 
(8 mm in diameter) and single draining
vein. Spot radiograph (B) shows deploy-
ment of 12 mm-diameter Amplatz
vascular plug (arrows). Left pulmonary
arteriogram (C) after embolotherapy
shows no evidence of pulmonary arteri-
ovenous malformation. Follow-up chest
radiograph (D) three months later shows
near-complete obliteration of previous
pulmonary arteriovenous malformation
shadow (arrows).
AB
CD(range: 4-40 mm) before embolotherapy to 0.68  2.30
mm (range: 0-10 mm) after embolotherapy (p < 0.001). In
the remaining three PAVMs, the aneurismal sac diameter
decreased, from 36 to 10 mm, from 8 to 6 mm and from
14 to 7 mm, respectively. There was no case of recanaliza-
tion or sac enlargement during follow up.
DISCUSSION
Twenty-three of the 25 consecutive patients with
PAVMs and who were referred for transcatheter
embolotherapy had sporadic PAVMs. In Western
countries, PAVMs are highly associated with HHT, which
is a common genetic disorder. The reports on HHT and
associated PAVMs have been limited in Asian countries. A
greater understanding of the characteristics of sporadic
PAVMs can help in their management. For example, we
found that respiratory symptoms were most common in
the patients with sporadic PAVMs, as was the incidental
detection of this condition. In contrast, the PAVMs associ-
ated with HHT were most commonly detected during
systemic screening for HHT (3). In the symptomatic
patients with PAVMs associated with HHT, respiratory
symptoms are more common than neurologic events, and
this is similar to our findings for patients with sporadic
PAVMs.
Little is known regarding the radiological characteristics
of sporadic PAVMs. We found that multiplicity (22%) was
less common, while PAVMs located in the lower lung zone
(63%) and peripheral locations (86%) were common.
These findings are similar to those of previous reports,
which also found that lower lobar (65-91%) and periph-
eral (73%) locations were common in patients with HHT-
associated PAVMs (5, 9, 11), although the incidence of
multiplicity in the peripheral locations was much higher
(35-65%) (3, 7, 11-13). We also found that the simple
type of angioarchitecture was more common in the
sporadic PAVMs (97%) than that in the HHT-associated
(80-92%) PAVMs (5, 9, 11). Yet the patients with HHT
are more likely to have multiple, variably sized lesions,
including microscopic lesions (3, 4, 6, 11). 
We found that 94% of all the visible PAVMs were
successfully embolized with no residual PAVM filling. It is
difficult to compare our technical success rate with that of
the previous reports because the parameters of technical
success in the previous reports was not described in detail
and 16-32% of the patients in the previous reports
required several sessions of embolotherapy (6, 9). We
observed failure of catheterization in one patient who had
nine PAVMs, and one of these in the right middle lobe
could not be catheterized. The unembolized PAVM did not
change in size. Catheterization failure has been reported to
be the most common cause of failure during the first
embolotherapy attempt, and so these cases required
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Fig. 3. 28-year-old male with small pulmonary arteriovenous malformation in right lower lobe (Patient No. 11). Right pulmonary arteri-
ogram (A) shows small pulmonary arteriovenous malformation (arrows) with single arterial feeder and single draining vein. Right
pulmonary arteriogram (B) after embolotherapy with placing two Nester coils shows no evidence of pulmonary arteriovenous malforma-
tion. Follow-up CT scan (C) after three weeks shows pulmonary infarction (arrows) distal to embolized pulmonary artery. 
ABCmultiple sessions of embolotherapy, and especially in the
cases where the feeding arteries were small (11). Another
patient had a feeding artery that was too large for
embolotherapy (17 mm). In this patient, the large draining
vein was too close to the right atrium, so embolotherapy
was not attempted. Even with using an occlusion balloon,
it would be difficult to occlude a feeding artery with such a
large diameter. Surgery is a good alternative in such cases.
An Amplatz vascular plug was successfully used in three
patients, and each of these three patients had a relatively
large feeding artery. This plug can be used for PAVMs with
larger arteries (up to 10 mm) and that have high flow,
where the alternative may be multiple coils (14, 15).
Complete or near-complete involution was observed in
30 of 33 embolized PAVMs (91%), with a significant
decrease of the sac size. This result is comparable to those
previously reported results, with complete or near
complete involution observed in 75-93% of the PAVMs in
38-155 patients, of whom most (84-96%) had PAVMs
associated with HHT (5, 6, 9). In contrast to these previous
studies, in which the rate of recanalization was reported to
be 2-19%, we observed no case of recanalization of
embolized PAVMs (5, 6, 9). The rate of recanalization
tends to be higher in complex PAVMs and lower in
patients with simple PAVMs (5). The persistence or
reperfusion of successfully embolized PAVMs has been
reported to occur during recanalization of the embolized
vessels, during growth of a missed or previously small
accessory artery and when there is collateral flow into the
pulmonary artery (6). No case of recanalization or sac
enlargement was noted in this study and this could be due
to the fact that the majority of the PAVMs were the simple
type of PAVMs where single arterial feeders were present,
and there were fewer cases of residual PAVMs. We found
that the arterial oxygen saturation level significantly
increased after embolotherapy. This improvement was
related to the improvement of respiratory symptoms in all
15 patients who displayed respiratory symptoms. 
Among the observed complications, one patient experi-
enced inadvertent coil embolization (4%), but subsequent
pulmonary infarction was not observed. Reflux or
migration of the coils within the pulmonary circulation has
been reported in 3-6% of patients (5, 16). These coils can
migrate to the aneurismal sac or they can reflux into the
normal branches of the pulmonary arteries without
sequelae. Dislocated coils can be retrieved (5). Three cases
of systemic embolization of coils to the mitral valve leaflet
or left ventricle have been reported (16, 17). Pulmonary
infarction has been reported to occur in 5% of embolother-
apy procedures (16). Hemoptysis or chest pain can also
occur. Pulmonary infarction may be associated with
pleurisy and a high frequency of abnormally enlarged
systemic arteries, which can place patients at risk for future
hemoptysis (5, 18). Although our patient with pulmonary
infarction showed neither pleurisy nor hemoptysis during
follow up, these sequelae should be kept in mind when
performing further follow-up imaging. 
The major limitation of this study was the small number
of PAVMs, although the study’s patients were collected in
a large tertiary referral hospital over an eight year period.
No comparisons were made with the PAVMs accompany-
ing HHT because these were much less common during the
study period. Another limitation was the retrospective
design of the study. In addition, the arterial oxygen satura-
tion measurements and CT scans before and after
embolotherapy were not available for all the patients.
In conclusion, our results indicate that sporadic PAVMs
are mostly the simple type with predominance in the lower
lobe and the periphery of the lung. Transcatheter
embolotherapy is a safe and effective treatment for
patients with sporadic PAVMs, and this procedure
provides excellent functional and radiological improve-
ment. 
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